Oppenheimer Has Lowered Expectations for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Bioceres Crop Solutions (NASDAQ:BIOX - Free Report) had its target price trimmed by Oppenheimer from $13.00 to $12.00 in a report released on Tuesday,Benzinga reports. The firm currently has an outperform rating on the stock.

Separately, Canaccord Genuity Group lowered their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating for the company in a report on Wednesday, November 13th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $11.88.

Bioceres Crop Solutions Trading Down 2.3 %

NASDAQ:BIOX traded down $0.16 on Tuesday, reaching $6.84. The company's stock had a trading volume of 122,001 shares, compared to its average volume of 208,305. The firm has a market cap of $429.06 million, a price-to-earnings ratio of 342.27 and a beta of 0.56. Bioceres Crop Solutions has a 12-month low of $5.71 and a 12-month high of $14.05. The stock has a 50 day moving average price of $6.68 and a 200 day moving average price of $8.03. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The company had revenue of $92.60 million during the quarter, compared to analysts' expectations of $117.15 million. During the same period last year, the firm posted ($0.07) earnings per share. On average, equities analysts anticipate that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Fourth Sail Capital LP raised its position in Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock valued at $24,957,000 after purchasing an additional 1,209,277 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after buying an additional 29,693 shares during the period. Dimensional Fund Advisors LP raised its holdings in Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock valued at $688,000 after acquiring an additional 5,341 shares in the last quarter. Ping Capital Management Inc. lifted its stake in Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock worth $268,000 after acquiring an additional 3,000 shares during the last quarter. Finally, Stifel Financial Corp grew its holdings in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock worth $321,000 after acquiring an additional 10,224 shares in the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.